江苏自贸试验区完善生物医药产品采购使用政策明确

Core Viewpoint - The Jiangsu Free Trade Zone aims to enhance the biopharmaceutical industry through innovative policies and practices, focusing on the integration of innovative drugs and medical devices into healthcare services [1] Summary by Relevant Sections Policy Enhancements - The plan emphasizes improving procurement and usage policies for biopharmaceutical products, with a focus on the early adoption of innovative drugs and devices to elevate healthcare service levels [1] National Insurance Integration - It is proposed that eligible innovative drugs be included in the national medical insurance drug list, optimizing the process for listing innovative drugs and improving efficiency [1] Technological Innovation - The initiative includes exploring pilot projects for artificial intelligence-assisted diagnostic technologies, expanding the scope of existing medical service pricing to include these new diagnostic services [1] Research and Development Support - The plan supports the implementation of significant national science and technology projects in the biopharmaceutical sector, aiming to overcome key technological challenges in innovative drugs and high-end medical devices [1] Data and AI Applications - There is a focus on enhancing the application of big data and artificial intelligence in drug target screening, molecular design, and the design and manufacturing of medical devices [1] Innovation Centers - The establishment of a national biopharmaceutical technology innovation center in the Suzhou area of the Jiangsu Free Trade Zone is supported, along with participation in national science and technology major projects [1]